11.12.2013 14:20 Uhr, Quelle: Wallstreet online
Enzo Biochem and Flagship Biosciences Partner to Provide Tissue-Based Companion Diagnostics Offering Complete Solution for In Situ Hybridization Development to Pharmaceutical Companies
Enzo Biochem Inc. (NYSE:ENZ) and Flagship Biosciences LLC, of Boulder, CO, today announced a partnership in tissue-based companion diagnostics that will enable personalized diagnosis and treatment of disease. The firms are …
Weiterlesen bei Wallstreet online
JustMac.info